Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction
about
BST2/tetherin inhibits dengue virus release from human hepatoma cellsEvolutionary conflicts between viruses and restriction factors shape immunityA Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin.BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1)HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.Novel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro.A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages.Molecular mechanism of arenavirus assembly and budding.The sheep tetherin paralog oBST2B blocks envelope glycoprotein incorporation into nascent retroviral virionsRestriction genes for retroviruses influence the risk of multiple sclerosis.HIV-1 replication in human immune cells is independent of TAR DNA binding protein 43 (TDP-43) expression.TLR ligands induce antiviral responses in chicken macrophages.BST2/tetherin inhibition of alphavirus exit.Increased BST2 expression during simian immunodeficiency virus infection is not a determinant of disease progression in rhesus monkeysLearning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.The broad-spectrum antiviral functions of IFIT and IFITM proteins.On the classification and evolution of endogenous retrovirus: human endogenous retroviruses may not be 'human' after all.The roles of ebolavirus glycoproteins in viral pathogenesis.Two retroviruses packaged in one cell line can combined inhibit the replication of HIV-1 in TZM-bl cells.Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses.BST-2/tetherin: viral tether, viral sensor or both?Tetherin antagonism by V proteins is a common trait among the genus Rubulavirus.The cytosolic N-terminus of CD317/tetherin is a membrane microdomain exclusion motif.Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity.BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection
P2860
Q21559656-C97B9135-9D34-4AA0-AAE3-BAB9835FBD2AQ27022032-6D7BDF55-451B-41B4-B85D-C06DFF91407AQ33292303-F8DB3B31-B213-44D4-B1AC-2428F2DB7916Q33861091-E7A269E1-C00C-4903-AEF5-F35707F5436FQ33887674-A90C5348-16E8-4C11-A7D4-E0C2BB698637Q34220959-DA87BDA1-02B2-42A1-9DFE-0B9C5BE6BCEFQ34323296-50424425-AC2E-4AEF-B4E2-0FB06F5781BCQ34426498-25878505-3843-4569-9BD2-BB7ADF12848BQ34645914-141CF00B-C9D6-4B14-B286-0EA69D40E378Q34992656-855FCAB3-A16A-453A-871F-4F82D5017662Q34997189-B55A2313-C3ED-4807-8381-11BC3D82270BQ35225635-42DF9F4A-2160-4112-ACBA-6D60BA2448C6Q35233485-494DD804-FAE4-4269-8F0E-9571844F7CFBQ35544442-556197ED-B91B-48E0-A8C1-F13546C2F1B8Q36270509-44162BD5-CA23-4A7F-AD9E-AD9AB2F1BB36Q36807121-8BCAE3CA-2393-49D7-AEE2-87FFE1639740Q37378819-D967C720-D2DA-4DDC-A204-B7DA8AE6B4E2Q37510562-FEBAC027-6C8C-49D3-96A3-B2163B378413Q37566736-EF533292-3780-4A5F-A84C-EE59DA312C9CQ38067210-38940929-8F9E-4E49-8FFC-3DFB4DC8442CQ38714218-690C2AE8-79EE-48C8-ACC7-0B58556E5693Q39010678-EC2E9ACB-3FD0-4D54-97CA-2FBC3E50E8D8Q39236886-77AC4B54-45B8-47F7-AB90-D89740FD138DQ39243642-5A3120CE-D840-457B-8EB5-611BECB02B53Q39278440-970892AC-8E81-4476-9576-A9B66198A129Q40217772-0EE39FB4-D127-48BB-8791-B073944B2DF3Q41762850-AAFCA02E-E956-4CE4-AFE8-BDED662E2AA7Q42266919-0EEA4F44-B17D-49B8-A39D-E4B8D31659FFQ56895711-063B6DEE-1C74-424B-A1DD-B073144D36B5
P2860
Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@ast
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@en
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@nl
type
label
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@ast
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@en
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@nl
prefLabel
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@ast
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@en
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Antiviral inhibition of envelo ...... ST-2: action and counteraction
@en
P2093
Anna Le Tortorec
Stuart J D Neil
Suzanne Willey
P2860
P304
P3181
P356
10.3390/V3050520
P407
P5008
P577
2011-05-01T00:00:00Z